Duplicate publication bias weakens the validity of meta-analysis of immunosuppression after transplantation
暂无分享,去创建一个
[1] Y. Soon,et al. Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma: An Updated Meta-Analysis and Meta-Regression of Randomized Trials. , 2018, International Journal of Radiation Oncology, Biology, Physics.
[2] Wei Zeng,et al. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. , 2014, World journal of gastroenterology.
[3] Jun Li,et al. Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials , 2014, Hepatology International.
[4] S. Knight,et al. Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta‐analysis , 2011, Transplant international : official journal of the European Society for Organ Transplantation.
[5] G. Otto,et al. Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial , 2010, Transplantation.
[6] E. Cholongitas,et al. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] G. Sgourakis,et al. Corticosteroid‐free immunosuppression in liver transplantation: a meta‐analysis and meta‐regression of outcomes , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[8] P. Thuluvath,et al. Steroid avoidance in liver transplantation: Meta‐analysis and meta‐regression of randomized trials , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] G Otto,et al. Tacrolimus Monotherapy Without Steroids After Liver Transplantation – A Prospective Randomized Double‐Blinded Placebo‐Controlled Trial , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] A. Dhillon,et al. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis , 2006, Transplant infectious disease : an official journal of the Transplantation Society.
[11] L. Belli,et al. Early cyclosporine monotherapy in liver transplantation: A 5‐year follow‐up of a prospective, randomized trial , 1998, Hepatology.
[12] C. Sansalone,et al. Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial. , 1997, Transplantation proceedings.
[13] F. Romani,et al. Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. , 1994, Transplantation proceedings.
[14] S. Wigmore,et al. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients. , 2018, The Cochrane database of systematic reviews.